Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Swedish biotech Calliditas has raised $90 million in an upsized US IPO and private placement, valuing the rare kidney and liver disease specialist at $467 million as the craze for biotech IPOs ...

That makes it the second-largest biotech IPO this year, after Acelyrin raised $540 million in May. The biotech is developing a radiopharmaceutical called RYZ101 in phase 3 trials for ...

Endiya actively assists portfolio companies with product rollouts, customer acquisition hiring, and preparing for future ...

The primary market is finally picking up its momentum as four new initial public offerings (IPOs) are all set to open for subscription next week, including Arisinfra Solutions IPO in the mainboard ...

Discover how PomDoctor Limited aims to revolutionize China's telehealth industry with a $15M IPO, despite facing stiff ...

Upcoming IPO: Grand Continent Hotels IPO will open for subscription on Thursday, March 20, and close on Monday, March 24. (https://grandcontinenthotels.com/) The ...